Literature DB >> 9644053

Novel quinone methides from Salacia kraussii with in vitro antimalarial activity.

J N Figueiredo1, B Räz, U Séquin.   

Abstract

Three novel quinone methides, i.e., 28-nor-isoiguesterin-17-carbaldehyde (1), 17-(methoxycarbonyl)-28-nor-isoiguesterin (2), and 28-hydroxyisoiguesterin (3), together with the known celastrol (5), pristimerin (6), and isoiguesterol (7), were isolated from the roots of Salacia kraussii (Celastraceae) by bioassay-guided fractionation. The structures of the compounds were determined by DEPT and 2D NMR techniques. The isolates showed antimalarial activity 30-50-fold greater than their cytotoxicity (in HT-29 cells) in vitro, and they showed an additive effect when combined with each other. In vivo, 2 was found to be inactive against blood stages of Plasmodium berghei in mice after oral and parenteral administration, and the compound was toxic with increasing concentrations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9644053     DOI: 10.1021/np9704157

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  16 in total

Review 1.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).

Authors:  Anita M Brinker; Jun Ma; Peter E Lipsky; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-01-23       Impact factor: 4.072

2.  Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets.

Authors:  Lada Klaić; Richard I Morimoto; Richard B Silverman
Journal:  ACS Chem Biol       Date:  2012-03-14       Impact factor: 5.100

3.  Searching for new antimalarial therapeutics amongst known drugs.

Authors:  Jennifer L Weisman; Ally P Liou; Anang A Shelat; Fred E Cohen; R Kiplin Guy; Joseph L DeRisi
Journal:  Chem Biol Drug Des       Date:  2006-06       Impact factor: 2.817

4.  Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.

Authors:  Xiaohua Gao; Yongbo Liu; Dorrah Deeb; Ali S Arbab; Subhash C Gautam
Journal:  J Exp Ther Oncol       Date:  2014

Review 5.  Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.

Authors:  H Yang; K R Landis-Piwowar; D Chen; V Milacic; Q P Dou
Journal:  Curr Protein Pept Sci       Date:  2008-06       Impact factor: 3.272

6.  Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway.

Authors:  Yong Bo Liu; Xiaohua Gao; Dorrah Deeb; Ali S Arbab; Subhash C Gautam
Journal:  J Carcinog Mutagen       Date:  2013-11-05

7.  Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.

Authors:  Lorillee C Tallorin; Jacob D Durrant; Quynh G Nguyen; J Andrew McCammon; Michael D Burkart
Journal:  Bioorg Med Chem       Date:  2014-09-15       Impact factor: 3.641

8.  The plant triterpenoid celastrol blocks PINK1-dependent mitophagy by disrupting PINK1's association with the mitochondrial protein TOM20.

Authors:  Conggang Zhang; Rongchun Wang; Zeyu Liu; Eric Bunker; Schuyler Lee; Michelle Giuntini; Douglas Chapnick; Xuedong Liu
Journal:  J Biol Chem       Date:  2019-03-18       Impact factor: 5.157

9.  Antifungal activity of maytenin and pristimerin.

Authors:  Fernanda P Gullo; Janaina C O Sardi; Vânia A F F M Santos; Fernanda Sangalli-Leite; Nayla S Pitangui; Suélen A Rossi; Ana C A de Paula E Silva; Luciana A Soares; Julhiany F Silva; Haroldo C Oliveira; Maysa Furlan; Dulce H S Silva; Vanderlan S Bolzani; Maria José S Mendes-Giannini; Ana Marisa Fusco-Almeida
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-22       Impact factor: 2.629

10.  Preventive Effects of Salacia reticulata on Obesity and Metabolic Disorders in TSOD Mice.

Authors:  Tomoko Akase; Tsutomu Shimada; Yukiko Harasawa; Tomohide Akase; Yukinobu Ikeya; Eiichi Nagai; Seiichi Iizuka; Gojiro Nakagami; Shinji Iizaka; Hiromi Sanada; Masaki Aburada
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.